证券代码：000525 证券简称：ST 红太阳 公告编号：2025－029 南京红太阳股份有限公司 关于公司股票交易撤销其他风险警示暨停复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 重要提示： 1、南京红太阳股份有限公司（以下简称"公司"）股票交易于 2025 年 6 月 12 日停牌一天，于 2025 年 6 月 13 日开市起复牌。 2、公司股票自 2025 年 6 月 13 日开市起撤销其他风险警示，股票简称由"ST 红太阳"变更为"红太阳"，股票代码仍为"000525"，撤销其他风险警示后，公司 股票交易日的涨跌幅限制由 5%变更为 10%。 3、公司因 2020 年至 2023 年度均被出具否定意见的内部控制审计报告，公 司存在最近一年（2023 年度）被出具否定意见的内部控制审计报告而触及的其 他风险警示情形，公司股票被实施其他风险警示。2024 年度公司内部控制审计 报告的意见类型为"标准无保留意见"，且公司 2023 年度内部控制审计报告否定 意见涉及事项影响已消除。 一、股票种类、简称、股票代码以及股票停复牌起始日 1、股票种类 ...

Core Viewpoint - ST Hongtai (000525) will suspend trading for one day on June 12, 2025, and resume trading on June 13, 2025, with the stock name changing from "ST Hongtai" to "Hongtai" and the stock code remaining the same [1] Summary by Relevant Sections - Trading Suspension and Resumption - The company will suspend its stock trading on June 12, 2025, and will resume trading on June 13, 2025 [1] - Change in Stock Name and Code - The stock name will change from "ST Hongtai" to "Hongtai," while the stock code "000525" will remain unchanged [1] - Adjustment of Trading Limits - The daily price fluctuation limit for the stock will increase from 5% to 10% starting June 13, 2025 [1] - Audit Report Status - The company received a negative opinion on its internal control audit reports for the years 2020 to 2023, which triggered other risk warning situations [1] - The internal control audit report for the year 2024 is expected to be standard with an unqualified opinion, and the issues related to the negative opinion in the 2023 report have been resolved [1]

Core Viewpoint - ST Hongtai announced a price adjustment for its 97% chlorantraniliprole product to 300,000 yuan per ton, a more than 40% increase compared to last year's low of 210,000 yuan per ton, primarily due to limited upstream raw material supply and rising costs [1][3]. Industry Overview - Chlorantraniliprole is the world's largest insecticide, with annual global sales exceeding $2 billion. After the expiration of its compound patent in China in August 2022, market prices continued to decline, with a cumulative drop of 34.38% in 2024. However, since 2025, prices have rebounded due to low effective capacity release influenced by intermediates and operating rates, rising to 228,000 yuan per ton on May 25, an increase of 8.57% [3]. - Currently, there are over 100,000 tons per year of chlorantraniliprole production capacity under construction or planning in China, but the progress of planned capacity construction has slowed due to the impact of intermediate K amine supply and declining raw material prices [3]. Market Reaction - Following the price adjustment announcement, the pesticide sector continued to show strength on June 9, with stocks such as Changqing Co. and Guangkang Biochemical hitting historical highs, and ST Hongtai and other stocks also rising [3]. - Analysts generally believe that chlorantraniliprole prices are likely to experience a phase of upward momentum. Future project approvals and production regulations involving hazardous chemical reactions such as nitration and chlorination are expected to become stricter, benefiting leading companies in the chemical industry that can maintain stable production of existing products [3]. Company Responses - Due to changes in market supply dynamics, investor interest in companies involved in chlorantraniliprole has increased, prompting several listed companies to respond. Lianhua Technology stated that it provides advanced intermediates through a CDMO model and does not directly produce the product, indicating limited overall impact on the company. Huailong Co. is steadily advancing its chlorantraniliprole raw material and intermediate project with an annual output of 2,000 tons. Lier Chemical is orderly constructing a 5,000 tons/year production facility. Changqing Co. confirmed that its insecticides are currently in normal production. Liming Co. noted that if chlorantraniliprole supply tightens, it would boost demand for alternatives such as abamectin and methomyl [4].

Core Viewpoint - The price of 97% chlorantraniliprole has been adjusted to 300,000 yuan/ton due to limited supply of upstream raw materials, marking an increase of over 40% compared to the low point of 210,000 yuan/ton last year. This price adjustment is expected to lead to a phase of price increase in the market for chlorantraniliprole [1][2]. Industry Summary - Chlorantraniliprole has a global annual sales exceeding $2 billion, making it the largest insecticide worldwide. It was discovered by the former DuPont company in 2000 and was first launched in 2008. The expiration of its compound patent in China on August 13, 2022, significantly changed the market landscape [2]. - Following the patent expiration, the market price of chlorantraniliprole continued to decline, with a cumulative drop of 34.38% from 320,000 yuan/ton at the beginning of 2024 to 210,000 yuan/ton by the end of the year. However, since 2025, prices have rebounded from 210,000 yuan/ton to 228,000 yuan/ton as of May 25, 2025, reflecting an increase of 8.57% [2]. - Currently, over 100,000 tons/year of chlorantraniliprole production capacity is under construction or planned in China. However, actual progress has been hindered by the supply of intermediates and the continuous decline in raw material prices [2]. Company Responses - Lianhua Technology announced that it provides advanced intermediates for chlorantraniliprole through a CDMO business model and does not directly produce chlorantraniliprole. The company has a long-term partnership with its client and has not received any notifications regarding increased demand for related products [3]. - Huayong Co. stated that it has an annual production capacity of 2,000 tons of chlorantraniliprole and intermediates, with steady progress in project construction [3]. - Lier Chemical expressed optimism about the market prospects for chlorantraniliprole and is currently constructing a production facility with a capacity of 5,000 tons/year [3]. - Liming Co. indicated that its products cover various categories of insecticides, and if chlorantraniliprole supply tightens, it may boost the demand for its widely used insecticides, such as abamectin and methomyl, which have overlapping efficacy with chlorantraniliprole [4]. - Industry insiders noted that if the price of chlorantraniliprole rises sharply in the short term, downstream users may opt for alternative insecticides, increasing the demand for substitutes [4].

南京红太阳股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 南京红太阳股份有限公司（以下简称"公司"） （证券代码：000525， 证券简称：ST红太阳）股票连续三个交易日（2025年6月5日、6月6 日、6月9日）收盘价涨幅累计偏离13.76%，根据深圳证券交易所的相 关规定，属于股票交易异常波动情形。 二、公司关注、核实情况说明 证券代码：000525 证券简称：ST 红太阳 公告编号：2025－027 生买卖公司股票的行为。 三、是否存在应披露而未披露信息的说明 公司董事会确认，除公司已披露的信息外，公司目前没有任何根 据《股票上市规则》等有关规定应予以披露而未披露的事项或与该事 项有关的筹划、商谈、意向、协议等；董事会也未获悉公司有根据《股 票上市规则》等有关规定应予以披露而未披露的、对公司股票交易价 格产生较大影响的其他信息。 四、风险提示 公司将严格按照《股票上市规则》等有关法律法规及其规章制度 要求，及时披露相关事项的进展。公司指定的信息披露媒体为《中国 证券报》《证券时报》及巨潮资讯网，公司所有信息均 ...

证券代码：000525 证券简称：ST 红太阳 公告编号：2025－027 南京红太阳股份有限公司 3、截至目前，除已披露的信息外，公司、公司控股股东及实际 控制人不存在关于公司的应披露而未披露的重大事项。 关于股票交易异常波动暨风险提示的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 南京红太阳股份有限公司（以下简称"公司"）（证券代码：000525， 证券简称：ST红太阳）股票连续三个交易日（2025年6月5日、6月6 日、6月9日）收盘价涨幅累计偏离13.76%，根据深圳证券交易所的相 关规定，属于股票交易异常波动情形。 二、公司关注、核实情况说明 针对公司股票交易异常波动，公司董事会向公司、公司控股股东 云南合奥产业合伙企业（有限合伙）及实际控制人曲靖高新技术产业 开发区管理委员会就相关事项进行了核实，现就有关情况说明如下： 1、目前，公司生产经营情况正常，公司高度重视安全生产并持 续开展环保治理工作，公司内外部经营环境未发生重大变化。2024 年度，公司实现营业收入 3,007,032,836.24 元，同比下降 ...

Group 1 - The agricultural pesticide sector continues its strong performance, with Changqing Co., Ltd. achieving a two-day consecutive limit-up [1] - Guangkang Biochemical surged over 15%, reaching a new historical high, while Lianhua Technology approached the limit-up [1] - Other companies such as Nuobixin, Yabenn Chemical, Hailier, and Huillong also experienced gains [1] Group 2 - On June 5, ST Hongtaiyang announced a price adjustment for its 97% chlorantraniliprole product, raising the price to 300,000 yuan per ton, with limited supply [1] - This price increase represents a more than 40% rise compared to the market's low point of 210,000 yuan per ton last year [1]

Investment Rating - The report maintains an "Overweight" rating for the chemical industry, specifically highlighting the potential in the pesticide sector due to recent price increases and supply constraints [5]. Core Insights - The pesticide industry in China is undergoing structural optimization driven by stringent environmental regulations, leading to a gradual increase in the market share of high-efficiency, low-risk pesticides while phasing out older, more toxic products [1][2]. - The recent explosion at Youdao Chemical has impacted the supply of chlorantraniliprole, which is expected to drive up prices due to supply constraints [2][3]. - The price index for pesticide raw materials has reached a low point, with a slight increase noted, indicating a potential turning point for channel inventory [1]. Summary by Sections 1. Pesticide Industry Overview - China's pesticide product structure is being optimized, with a focus on reducing the use of high-risk products and increasing the market share of new, efficient pesticides [1]. - The pesticide raw material price index as of May 30, 2025, is 73.33 points, reflecting a 0.44 point increase since the beginning of the year [1]. 2. Supply Chain Impact - The explosion at Youdao Chemical on May 27, 2025, has disrupted the supply of chlorantraniliprole, which is the largest production facility globally with a capacity of 11,000 tons [2]. - The incident is expected to lead to stricter approvals and regulations for high-risk chemical reactions, benefiting leading chemical companies with better safety protocols and production technologies [2]. 3. Price Adjustments - ST Hongtai has raised the price of chlorantraniliprole to 300,000 yuan per ton due to increased costs from upstream raw material shortages [3]. - As of May 30, 2025, the market price for chlorantraniliprole was reported at 230,000 yuan per ton, marking a 2.22% increase from the previous day [3]. 4. Investment Recommendations - The report suggests focusing on undervalued, high-dividend, and well-performing companies in the oil and gas sector, as well as those benefiting from domestic substitution trends in materials [4]. - Specific companies to watch include China Petroleum, China Petrochemical, and Wanhu Chemical, among others [4].

Core Viewpoint - The recent price increase announcement by Hongyang has sparked enthusiasm in the agricultural chemicals industry, driven by rising costs of upstream raw materials and limited supply [1][3]. Company Summary - Hongyang has adjusted the price of its 97% chlorantraniliprole product to 300,000 yuan per ton due to a sharp increase in production costs [1][3]. - The company currently has an annual production capacity of 2,000 tons of chlorantraniliprole, with an additional 1,000 tons expected to be completed by September this year [8]. - Hongyang holds a market share of approximately 35% in the chlorantraniliprole market, supported by a complete upstream supply chain and advanced production processes [7]. Industry Summary - The price surge in chlorantraniliprole is largely attributed to the explosion at Shandong Youdao Chemical on May 27, which resulted in significant supply chain disruptions and a 40% reduction in global supply [9]. - Following the explosion, the market price of chlorantraniliprole rose from 228,000 yuan per ton on May 26 to 300,000 yuan per ton by June 4, reflecting a volatile market environment [9]. - The industry is expected to undergo a period of deep integration, with leading companies leveraging their technological and scale advantages, while smaller firms may need to find niche markets for survival [10]. - Demand for chlorantraniliprole is currently strong in Southeast Asia and is expected to grow in South America, indicating a positive outlook for overseas demand [10].

Core Viewpoint - ST Hongtai (SZ000525) announced a price adjustment for its 97% chlorantraniliprole product to 300,000 yuan/ton due to upstream raw material shortages, leading to a stock price surge and increased interest in related stocks [1][3][6]. Company Summary - ST Hongtai's stock price reached a limit-up on June 5, closing at 7.79 yuan, with a market capitalization of 10.112 billion yuan [1]. - The company cited a significant increase in production costs due to limited supply of upstream raw materials, prompting the price adjustment [3][6]. - ST Hongtai holds a market share of approximately 35% in the chlorantraniliprole sector and plans to establish a circular economy industrial chain project with an annual capacity of 6,000 tons by 2025 [6]. Industry Summary - The chlorantraniliprole market is experiencing tight supply, exacerbated by an explosion at Shandong Youdao Chemical Co., which accounted for 40.4% of the industry's total production capacity [7]. - The price of chlorantraniliprole has increased by over 40% compared to last year's low, with current prices around 300,000 yuan/ton, while the original price was approximately 210,000 yuan/ton [8]. - Demand for chlorantraniliprole is expected to remain strong, particularly in Southeast Asia and South America, as the market is entering a peak demand season [8].